Authors: Bijker, N Rutgers, EJT Peterse, JL Fentiman, IS Julien, JP Duchateau, L van Dongen, JA

Citation: N. Bijker et al., Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS, EUR J SUR O, 27(2), 2001, pp. 135-140

Authors: Voogd, AC Nielsen, M Peterse, JL Blichert-Toft, M Bartelink, H Overgaard, M van Tienhoven, G Andersen, KW Sylvester, RJ van Dongen, JA

Citation: Ac. Voogd et al., Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials, J CL ONCOL, 19(6), 2001, pp. 1688-1697

Authors: van Dongen, JA Voogd, AC Fentiman, IS Legrand, C Sylvester, RJ Tong, D van der Schueren, E Helle, PA van Zijl, K Bartelink, H

Citation: Ja. Van Dongen et al., Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial, J NAT CANC, 92(14), 2000, pp. 1143-1150

Authors: van Tienhoven, G Voogd, AC Peterse, JL Nielsen, M Andersen, KW Mignolet, F Sylvester, R Fentiman, IS van der Schueren, E van Zijl, K Blichert-Toft, M Bartelink, H van Dongen, JA

Citation: G. Van Tienhoven et al., Prognosis after treatment for loco-regional recurrence after mastectomy orbreast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM), EUR J CANC, 35(1), 1999, pp. 32-38

Authors: Vrouenraets, BC in't Veld, GJ Nieweg, OE van Slooten, GW van Dongen, JA Kroon, BBR

Citation: Bc. Vrouenraets et al., Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan, EUR J SUR O, 25(5), 1999, pp. 503-508

Authors: Bijker, N Rutgers, EJT Peterse, JL van Dongen, JA Hart, AAM Borger, JH Kroon, BBR

Citation: N. Bijker et al., Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy, CANCER, 85(8), 1999, pp. 1773-1781